Research output per year
Research output per year
Search results
-
2023
Coronavirus vaccines
Dervillez, X., Léonard, C. & Ollert, M., 12 Jan 2023, IPC No. A61K39/12; A61P31/14; C07K14/78;, Patent No. WO2023280998A1, Priority date 7 Jul 2021, Priority No. EP2022068951W·2022-07-07Research output: Patent
Open Access -
Multifunctional Heteromultimeric Constructs
Dervillez, X., Seguin-Devaux, C. & Cohen, J. H. M., 27 Apr 2023, IPC No. US 2023/0130737 A1Research output: Patent
-
2022
Inhibitor of DJ-1 for Use in Treating Immunoaging
Hefeng, F. Q., Ollert, M. & Balling, R., 24 Nov 2022, IPC No. US 20220370605A1Research output: Patent
-
2021
Specific ACKR2 modulators for use in therapy
Janji, B., Noman, M. Z., Chevigne, A., Szpakowska, M., Berchem, G. & Ollert, M., 21 Jan 2021, IPC No. A61K39/395; A61K48/00; A61P35/00; C07K16/28; C12N15/113, Patent No. WO 2021/009251, 15 Jul 2020, Priority date 15 Jul 2019, Priority No. EP19186373AResearch output: Patent
Open Access -
2019
Hydrogel embedded oligodoxynucleotides as tolerognic adjuvant for subcutaneous immunotherapy
Bredehorst, R., Grunwald, T., Léonard, C. & Ollert, M., 24 Apr 2019, IPC No. WO 2019/076478Research output: Patent
-
Induction of allergen-specifi Tregs prior to oral or sublingual immunotherapy of food allergy
Bredehorst, R., Grunwald, T., Léonard, C. & Ollert, M., 25 Apr 2019, IPC No. WO 2019/076477Research output: Patent
Open Access -
2017
Matrix-embedded Tolerance-promoting Adjuvants for subcutaneous lmmunotherapy
Bredehorst, R., Grunwald, T. & Ollert, M., 6 Dec 2017, IPC No. EP3251662, US2018/0085452Research output: Patent